PEOPLE - Changes at LifeCell:
This article was originally published in Clinica
Developer and marketer of regenerative human tissue LifeCell (Branchburg, New Jersey) has expanded its board of directors. Michael Minogue and Robert Roche have been appointed, to be effective from October 1. Mr Minogue is chairman of the board, CEO and president of US cardiac pump maker Abiomed. Prior to this he held various senior management positions at GE Medical Systems. Mr Roche is executive vice-president, worldwide pharmaceutical operations for biopharma firm Cephalon, based in the US.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.